Accenture has placed a bold wager on operational technology, spending roughly $4.1 billion to acquire a majority stake in Dragos, a specialist in industrial cybersecurity. The consulting giant is also buying runZero and NetRise outright, folding both companies into the Dragos structure. The newly formed unit is expected to generate $208 million in recurring revenue by the summer of 2026. The move marks a deliberate shift from traditional IT services into higher-margin software, with Accenture betting on the fast-growing market for protecting critical infrastructure — a segment analysts project will reach nearly $59 billion by 2031.
The acquisition spree comes at a precarious moment for the stock. Accenture’s shares have lost roughly half their value since the start of 2026, sliding to €112.85 after hitting a 52-week low of €103.60 on June 22. The catalyst was a disappointing Q3 report: revenue rose 6% to $18.7 billion, and GAAP earnings per share hit $3.80, beating expectations, but the company then cut its full-year growth forecast, trimming the upper end from 5% to 4%. Investors fled, with the stock plunging 18% in a single session.
Wall Street has responded by trimming its enthusiasm. Morgan Stanley downgraded Accenture to Equal-weight and slashed its price target from $240 to $177, citing uncertainty around the pace of AI-driven disruption. Berenberg also cut its target to $220, while acknowledging that Accenture remains well positioned in a shifting landscape. The analyst community is split: those with “Strong Buy” ratings point to the company’s strengthened cybersecurity and AI capabilities as long-term free cash flow drivers.
Should investors sell immediately? Or is it worth buying Accenture?
Accenture has not sat idle. In addition to the cyber acquisitions, the board authorized a $2 billion increase to the existing share repurchase program and raised the quarterly dividend by 10%. These moves are designed to reassure investors who fled after the guidance cut. Yet the market’s reaction has been muted — the stock remains 56% off its 52-week high of €259.25 from July 2025, and the 50-day moving average of €146.57 is still 23% above the current price, underscoring how far the shares are from any semblance of a technical recovery.
From a technical perspective, the stock is deeply oversold. The relative strength index stands at 28.7, a level contrarian investors often view as a potential stabilization point. However, the price still trades 41% below its 200-day moving average, a sign that any genuine upturn is a long way off. Management’s next opportunity to restore confidence comes in August and September, when the Dragos, runZero, and NetRise acquisitions are expected to close. Should the fourth quarter — for which Accenture has already lowered its own bar — hit or exceed the revised targets, the buyback program could help accelerate a recovery. A miss would likely add to the pressure.
Ad
Accenture Stock: Buy or Sell?! New Accenture Analysis from June 29 delivers the answer:
The latest Accenture figures speak for themselves: Urgent action needed for Accenture investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from June 29.
Accenture: Buy or sell? Read more here...
